Correlation Between ImmuPharma PLC and International Consolidated

Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and International Consolidated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and International Consolidated into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ImmuPharma PLC and International Consolidated Airlines, you can compare the effects of market volatilities on ImmuPharma PLC and International Consolidated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of International Consolidated. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and International Consolidated.

Diversification Opportunities for ImmuPharma PLC and International Consolidated

-0.92

Correlation Coefficient

ImmuPharma PLC  International Consolidated

Pay attention - limited upside

The 3 months correlation between ImmuPharma and International is -0.92. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and International Consolidated Air in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International Consolidated and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with International Consolidated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International Consolidated has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and International Consolidated go up and down completely randomly.

Pair Corralation between ImmuPharma PLC and International Consolidated

Assuming the 90 days trading horizon ImmuPharma PLC is expected to under-perform the International Consolidated. In addition to that, ImmuPharma PLC is 5.3 times more volatile than International Consolidated Airlines. It trades about -0.15 of its total potential returns per unit of risk. International Consolidated Airlines is currently generating about 0.81 per unit of volatility. If you would invest  24,600  in International Consolidated Airlines on September 23, 2024 and sell it today you would earn a total of  5,980  from holding International Consolidated Airlines or generate 24.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

ImmuPharma PLC  vs.  International Consolidated Air

ImmuPharma PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ImmuPharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

International Consolidated

Risk-Adjusted Performance

27 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in International Consolidated Airlines are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, International Consolidated exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ImmuPharma PLC and International Consolidated

The main advantage of trading using opposite ImmuPharma PLC and International Consolidated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, International Consolidated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Consolidated will offset losses from the drop in International Consolidated's long position.

The idea behind ImmuPharma PLC and International Consolidated Airlines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.